The alternative non-homologous end-joining (NHEJ) machinery facilitates several genomic rearrangements, some of which can lead to cellular transformation. This error-prone repair pathway is triggered upon telomere de-protection to promote the formation of deleterious chromosome end-to-end fusions [1] [2] [3] . Using next-generation sequencing technology, here we show that repair by alternative NHEJ yields non-TTAGGG nucleotide insertions at fusion breakpoints of dysfunctional telomeres. Investigating the enzymatic activity responsible for the random insertions enabled us to identify polymerase theta (Polh; encoded by Polq in mice) as a crucial alternative NHEJ factor in mammalian cells. Polq inhibition suppresses alternative NHEJ at dysfunctional telomeres, and hinders chromosomal translocations at non-telomeric loci. In addition, we found that loss of Polq in mice results in increased rates of homology-directed repair, evident by recombination of dysfunctional telomeres and accumulation of RAD51 at double-stranded breaks. Lastly, we show that depletion of Polh has a synergistic effect on cell survival in the absence of BRCA genes, suggesting that the inhibition of this mutagenic polymerase represents a valid therapeutic avenue for tumours carrying mutations in homology-directed repair genes.
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The alternative non-homologous end-joining (NHEJ) machinery facilitates several genomic rearrangements, some of which can lead to cellular transformation. This error-prone repair pathway is triggered upon telomere de-protection to promote the formation of deleterious chromosome end-to-end fusions [1] [2] [3] . Using next-generation sequencing technology, here we show that repair by alternative NHEJ yields non-TTAGGG nucleotide insertions at fusion breakpoints of dysfunctional telomeres. Investigating the enzymatic activity responsible for the random insertions enabled us to identify polymerase theta (Polh; encoded by Polq in mice) as a crucial alternative NHEJ factor in mammalian cells. Polq inhibition suppresses alternative NHEJ at dysfunctional telomeres, and hinders chromosomal translocations at non-telomeric loci. In addition, we found that loss of Polq in mice results in increased rates of homology-directed repair, evident by recombination of dysfunctional telomeres and accumulation of RAD51 at double-stranded breaks. Lastly, we show that depletion of Polh has a synergistic effect on cell survival in the absence of BRCA genes, suggesting that the inhibition of this mutagenic polymerase represents a valid therapeutic avenue for tumours carrying mutations in homology-directed repair genes.
Chromosome end-to-end fusions are inhibited by shelterin; a multisubunit complex anchored to telomeric DNA by two Myb-containing proteins-TRF1 and TRF2 (ref. 4) . Telomere fusions are executed by two independent end-joining pathways. Classical non-homologous endjoining (C-NHEJ), mediated by LIG4 and the Ku70/80 heterodimer, is primarily blocked by TRF2 (ref. 5) . Conversely, alternative NHEJ (alt-NHEJ), which is dependent on LIG3 (ref. 6 ) and PARP1 (ref. 7) , is repressed in a redundant manner 2, 3 . Alt-NHEJ is fully unleashed after the simultaneous deletion of TRF1 and TRF2, and the creation of shelterinfree telomeres in cells deficient for Ku70 and Ku80 (also known as Xrcc6 and Xrcc5, respectively) 2 . This error-prone end-joining pathway mediates fusion of naturally eroded telomeres 1 , joining of switch regions during class-switch recombination 8 , and formation of chromosomal translocations in mouse cells 9, 10 . To characterize the differences between C-NHEJ and alt-NHEJ at dysfunctional telomeres, we determined whether the sequence of the junction between two fused telomeres differed depending on the type of repair pathway used. Telomere fusions by C-NHEJ were triggered by Cremediated depletion of TRF2 using previously described mouse embryonic fibroblasts (MEFs) (Trf2 Cre-ER T2 ) 11 (Extended Data Fig. 1a ). To induce robust fusions by the alt-NHEJ pathway, we depleted the entire shelterin complex by deleting Trf1 and Trf2 from Trf1 F/F Trf2 F/F Ku80
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Cre-ER T2 MEFs 2 (Extended Data Fig. 1a ). DNA was subjected to nextgeneration sequencing, and reads corresponding to telomeres were identified on the basis of the presence of at least three consecutive TTAGGG repeats. To detect rare reads containing fusion junctions, we exploited the novel sequence arrangement created by the ligation of the 39 G-rich strand (TTAGGG-39) to the 59 C-rich strand (59-CCCTAA) (Fig. 1a) , and filtered reads that started with at least three G-rich repeats and ended with two or more C-rich repeats. We confirmed that this approach could successfully identify telomere fusions by comparing reads derived from by alt-NHEJ. a, Schematic of the junction of a telomere fusion. The 39 end of the telomeric G-rich strand of a chromosome (blue) is fused to the 59 end of the C-rich strand of a different chromosome (red). b, Illumina sequencing to analyse telomere fusion junctions. Reads $3XTTAGGG consecutively were scored as derived from telomere fragments. Those with $3XTTAGGG on the 59 end and $2XCCCTAA at the 39 end were scored as telomere fusion junctions (see Supplementary Information) . c, Examples of telomere fusions generated by C-NHEJ of TRF2-depleted telomeres. Light grey highlights fusion junctions, dark grey marks the flanking telomere repeats. d, Examples of insertions in shelterin-free Ku80-null MEFs. e, Telomere fusions in metaphase spreads from Trf1 F/F Trf2 F/F Ku80 2/2 Cre-ER T2 MEFs. Telomeres in red (peptide nucleic acid (PNA) probe) and chromosomes in blue (49,6-diamidino-2-phenylindole; DAPI). f, Frequency of telomere fusions after the depletion of candidate polymerases. 4-OHT, 4-hydroxytamoxifen; shCtrl, control shRNA. Bars represent mean of n . 1,000 chromosome ends derived from one experiment. cells (Fig. 1b) . Sequence analysis of the junctions highlighted different permutations of TTAGGG/AATCCC sequences. Notably, the spectrum of the fusion junctions was different in shelterin-free settings, in which frequent non-telomeric nucleotide insertions (9 out of 46 events) were identified at fusion breakpoints (Fig. 1b-d and Supplementary Information).
To identify the enzyme that incorporated nucleotides at dysfunctional telomeres, we depleted known low-fidelity DNA polymerases in shelterinfree cells lacking Ku80, and analysed chromosome-end fusions on metaphase spreads. Notably, we observed a reduction in the frequency of telomere fusions in cells with reduced levels of polymerase theta (Polh, encoded by Polq in mice) (Fig. 1e, f and Extended Data Fig. 1b) . The activity of Polh is specific to alt-NHEJ as its inhibition in Trf2-knockout cells did not affect the frequency of C-NHEJ (Fig. 2a, b and Extended Data Fig. 2a-c) .
Polh is an A-family DNA polymerase that exhibits low fidelity on templated DNA 12 , and also displays a terminal transferase-like activity that catalyses nucleotide addition in a template-independent manner 13 . The relevance of these activities in vivo was highlighted in Drosophila melanogaster, in which Polh was shown to stimulate nucleotide insertions during double-stranded break (DSB) repair by alt-NHEJ 14 . More recently, Polh was shown to promote end-joining of replication-associated DSBs in Caenorhabditis elegans 15 , preventing large deletions around G-rich DNA 16 . The exact function of Polh during DSB repair in mammalian cells remains elusive.
The crucial role for Polh at dysfunctional telomeres prompted us to test whether it is required for DSB repair at non-telomeric loci. To this end, we tested whether the depletion of Polh affects chromosomal translocations in the context of mouse pluripotent cells, reported to be mediated by alt-NHEJ 10 in a LIG3-dependent manner 9 . To model chromosomal translocations, we induced DSBs in the Rosa26 and H3f3B mouse loci using the CRISPR/Cas9 system (Fig. 2c) Fig. 2g-k) . Altogether, our data indicate that the promiscuous activity of Polh during DSB repair contributes to the increased mutagenicity of alt-NHEJ. Importantly, our results indicate that mammalian Polh plays a critical part by stimulating the end-joining reaction.
We next investigated the upstream signalling event(s) required for the recruitment of Polh to DNA damage sites, induced after microirradiation of HeLa cells expressing Myc-tagged Polh. Accumulation of Polh at laser-induced DNA breaks, discerned by its co-localization with the phosphorylated histone H2AX (c-H2AX), occurred in ,25% of cells that stained positive for Myc (Fig. 3a, b) , and was independent of either ATM or ATR signalling (Extended Data Fig. 6 ). Instead, 
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co-localization of Polh with c-H2AX was reduced after depletion of PARP1 with short interfering RNAs (siRNAs), or after the inhibition of PARP1 activity (using KU58948) (Fig. 3a, b) . In a parallel experiment that used a recently developed U2OS-DSB reporter cell line 18 , we were able to ascertain the localization of Myc-Polh to bona fide DSBs, induced after FOK1 cleavage of a LacO-tagged genomic locus (Extended Data Fig. 7 ). In conclusion, our data suggest that PARP1, previously known to be required for alt-NHEJ 7, 19 , facilitates the recruitment of Polh to DSBs.
Homology-directed repair (HDR) is prevalent during the S/G2 phase of the cell cycle, which coincides with the peak of alt-NHEJ activity, and these pathways also share the initial resection step mediated by MRE11 and CtIP 20 . To test whether inhibiting alt-NHEJ could potentially result in increased HDR, we depleted shelterin in Lig4-deficient MEFs, a genetic setting that is conducive to the activity of alt-NHEJ as well as HDR 2 . To investigate the relative contribution of the two repair pathways, we used a chromosome-orientation fluorescence in situ hybridization (CO-FISH) assay 21 , and monitored the exchange of telomeres between sister chromatids by HDR (telomere sister chromatid exchange, T-SCE), and, at the same time, measured the frequency of chromosome end-end fusion by end-joining (Fig. 3c ). After depletion of shelterin from Trf1 F/F Trf2
Cre-ER T2 MEFs, ,10% of the telomeres were processed by alt-NHEJ, whereas ,5% of chromosome ends showed T-SCEs 2 ( Fig. 3c , d and Extended Data Fig. 8a-c ). As expected, we observed a substantial reduction in the frequency of alt-NHEJ at shelterin-free telomeres in Lig4 2/2 cells that lack Polq or Lig3 ( Fig. 3d and Extended Data Fig. 8a -e). Remarkably, Polq-depleted cells exhibited a concomitant increase in T-SCE, which was not evident in cells lacking Lig3 (Fig. 3d) , thereby highlighting a unique role for Polh in counteracting HDR. To gain insight into this novel Polh function, we show that the promiscuous polymerase is not required for end-resection of DSBs (Extended Data Fig. 8f, g ). Instead, its activity counteracts the accumulation of RAD51 foci (Fig. 3e, f and Extended Data Fig. 8h ). To corroborate these findings, we used the traffic light reporter (TLR) system, designed to generate a flow-cytometric readout for HDR and end-joining at a site-specific DNA break induced by I-Sce1 (ref. 22) . We observed that after knocking down Polq in Lig4 2/2 cells, resolution of the I-Sce1-induced DNA break by HDR is increased, in conjunction with a significant reduction in the frequency of alt-NHEJ (Extended Data Fig. 9 ).
Alt-NHEJ is often considered as a back-up choice for DSB repair, operating at the expense of genomic stability. Circumstantial evidence suggests that this pathway could be enhanced when HDR is impaired 23, 24 . We therefore postulated that this error-prone mode of repair has an essential role in cells with compromised HDR activity. We tested this hypothesis by inhibiting Polq in cells lacking the breast cancer susceptibility genes-Brca1 and Brca2. Chromosome analysis revealed a fourfold increase in chromosomal aberrancies after Polq depletion in MEFs lacking either Brca1 or Brca2. Such aberrancies included chromatid and chromosome breaks, in addition to radial chromosome structures characteristic of Lig4-mediated processing of chromatid breaks via the C-NHEJ pathway (Fig. 4a, b and Extended Data Fig. 10a, b) . Ultimately, the increased genomic instability in cells co-depleted for Polq and Brca genes compromised cellular survival. We observed that BRCA1-mutated human cells (Fig. 4c, d) , and mouse cells lacking Brca1 (Extended Data Fig. 10c-f) , displayed significantly reduced colony-forming capabilities after Polq impairment. Although we cannot exclude that Polh performs additional activities required for the survival of Brca-deficient cells 25 , our data suggest that Polh-mediated alt-NHEJ promotes the survival of cells with a compromised HDR pathway. In the absence of a safer means to repair breaks, alt-NHEJ may therefore prevent genomic havoc by resolving unrepaired lesions.
Here we provide direct evidence linking Polh to alt-NHEJ repair in mammalian cells (Fig. 4e) . We also show that while Polh hinders error-free repair by HDR, its activity is essential for the survival of HDR-deficient cells (Fig. 4e) . The question remains as to how this promiscuous polymerase orchestrates DSB repair. After DSB formation in the S/G2 phase of the cell cycle, resection of DSBs by MRE11 and CtIP 20 potentially exposes micro-homology that allows spontaneous annealing of broken DNA ends (Fig. 4e) . The binding of RPA antagonizes this annealing step to promote HDR-mediated repair 26, 27 . An opposing activity is likely to be exerted by Polh. Placing our finding in the context of recent biochemical experiments and genetic studies in model organisms [13] [14] [15] [16] , we ultimately propose a model in which Polh exploits both its templateindependent and template-dependent activities to stabilize the annealed intermediate structure and channel repair towards the alt-NHEJ pathway (Fig. 4e) . Our findings that Polh is critical for alt-NHEJ support this model, which provides a potential explanation as to how this polymerase counteracts HDR. 
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Finally, it is intriguing that although POLQ expression in normal human tissues is generally repressed 28 , it is upregulated in a wide range of human cancers and associates with poor clinical outcome in breast tumours 29, 30 . Our findings that cells with compromised HDR activity depend on this mutagenic polymerase for survival establish a rationale for the development of Polh-targeted approaches for cancer treatment.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Cre-ER T2 MEFs were derived from mice that were deficient in p53. The remaining MEF lines were immortalized with pBabeSV40LargeT. MEFs were cultured in DMEM supplemented with 10-15% FBS (Gibco), 2 mM L-glutamine (Sigma), 100 U ml 21 penicillin (Sigma), 0.1 mg ml 21 streptomycin (Sigma), 0.1 mM non-essential amino acids (Invitrogen) and 1 mM sodium pyruvate (Sigma). Expression of Cre recombinase was induced by treating MEFs carrying the Cre-ER T2 allele with 0.5 mM 4-OHT (Sigma H7904) for 12 h. The t 5 0 time point was set at the time of treatment with 4-OHT. BJ-hTERT and MCF7 cells were grown in DMEM supplemented with 10% FBS. HCC1937 cells were grown in RPMI medium (Gibco) containing 15% FBS. U2OS-DSB reporter cells were grown in DMEM supplemented with 10% BCS. Human HeLa cells were grown in DMEM supplemented with 10% FBS, 100 U ml 21 penicillin, 100 mg ml 21 streptomycin and 2 mM L-glutamine. Mouse embryonic stem cells were grown in DMEM supplemented with 15% FBS (ESqualified FBS) (Gibco), 2 mM L-glutamine (Sigma), 100 U ml 21 penicillin (Sigma), 0.1 mg ml 21 streptomycin (Sigma), 0.1 mM non-essential amino acids (Invitrogen), leukaemia inhibitory factor (LIF) and 2-b-mercaptoethanol (Gibco 21985). For inhibitor experiments, PARPi (KU58948, Axon medchem), ATMi (KU-55933, Tocris) and ATRi (VE-821, Selleckchem) were all used at a final concentration of 10 mM, and were applied to culture medium 2-4 h before irradiation. For ionizing radiation treatment, cells were exposed to 1-10 Gy ionizing radiation by a Faxitron X-ray system (120 kV, 5 mA, dose rate 5 Gy min
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) and recovered for 4 h before immunofluorescence analysis. Lentiviral delivery of shRNA. shRNA treatments were carried out before 4-OHT treatment. shRNAs (see below for a list of sequences) were introduced by two lentiviral infections at 12 h intervals using supernatant from transfected 293T cells. Parallel infection with pLK0.1 was used as a negative control. Cells were selected with puromycin for 3 days. TLR assay. Lentiviral constructs coding for TLR (31482) and I-Sce1 with donor e-GFP (31476) were purchased from Addgene 22 . To avoid the confounding effect of classical-NHEJ on the repair of I-Sce1-induced DNA breaks, we stably integrated the TLR construct into Ku80 2/2 and Lig4 2/2 MEFs. The plasmid was transduced by two lentiviral infections at 12 h intervals using supernatant from transfected 293T cells. Cells with integrated TLR were selected with puromycin for 5 days. Cells were then transduced with concentrated Polq shRNA lentiviral particles followed by I-Sce1. Cells were collected 72 h later without further antibiotic selection and analysed on a BD LSRII. eGFP fluorescence, which reflects HDR repair, was measured using a 488-nm laser for excitation and a 530/30 filter for detection. mCherry fluorescence, indicative of alt-NHEJ was measured by using a 561-nm laser for excitation and a 610/20 filter for detection. Data were analysed using FloJo software. Detection of telomeric fusions. To enrich for telomeric DNA, genomic DNA was digested with two frequent cutters (AluI and MboI) and fragments greater than 10 kilobases (kb) were isolated. The resulting DNA was used to generate a library using the NEBNext Ultra Library Prep Kit and the NEBNext Multiplex Oligos for Illumina (NEB) following the manufacturer instructions. The resulting library was run on an Illumina HiSeq platform generating 100-base-pair (bp) indexed pairend reads. Transient transfection of cells and laser micro-irradiation. Full-length human POLQ was cloned into pLPC-Myc vectors. HeLa cells were plated on glass-bottomed dishes (Willco Wells). Myc-Polh constructs were transfected into HeLa and U2OS-DSB reporter cells cell with HilyMax (Dojindo) according to the manufacturer's instruction. Then, 24 h after transfection, cells were pre-sensitized with 10 mM 5-bromo-29-deoxyuridine (BrdU) in normal DMEM medium for 20 h. After indicated treatments, cells were damaged by laser micro-irradiation as previously described 31 . After laser micro-irradiation, cells were incubated for 1 h, then fixed and analysed by immunofluorescence and microscopic imaging as described below. For PARP1 siRNA experiments, cells were transfected with siCtrl (non-targeting pool, Thermo Scientific) or siPARP1 (GGGCAAGCACAGUGUCAAAUU, Sigma), for 24 h before POLQ transfections and subsequent treatments as described above. Immunofluorescence and confocal microscopy. After the indicated treatments, cells were processed and analysed for immunofluorescence as previously described 32 .
In brief, cells were fixed with 2% (v/v) paraformaldehyde for 15 min at room temperature. Cells were washed with PBS, permeabilized with 0.5% (v/v) Triton X-100 for 10 min, and blocked with PBS containing 3% BSA. Cells were incubated with the same buffer containing primary antibodies for 1 h at room temperature followed by secondary antibodies incubations for 1 h at room temp. Cells were imaged and analysed with Z-stacked setting using the FV10-ASW3.1 software on a Fluoview 1000 confocal microscope (Olympus). For laser line quantification, .50 cells were counted for all conditions from two independent experiments. The primary antibodies used for immunofluorescence were c-H2AX (p Ser139) (rabbit polyclonal, Novus, NB100-384) and c-Myc (mouse monoclonal, Santa Cruz, sc-40). The secondary antibodies used for immunofluorescence were Alexa Fluor 594 (rabbit) (Invitrogen, A11037) and Alexa Fluor 488 (mouse) (Invitrogen, A11029). To analyse the recruitment of Polh to double-stranded breaks, U2OS-DSB reporter cells expressing Myc-Polh were analysed 4 h after treatment with shield and tamoxifen. Lastly, to analyse RAD51 foci formation and its co-localization with c-H2AX (p Ser139) after ionizing radiation treatment, cells were treated with 0.2% Triton X-100 (in PBS) for 5 min on ice before fixation with paraformaldehyde. The primary antibodies used for RAD51 immunofluorescence were c-H2AX (p Ser139) (mouse monoclonal, Novus, NB100-384) and RAD51 (rabbit polyclonal, Santa Cruz, sc-8349). FISH. Cells were collected at 96 h after treatment with 4-OHT to analyse the frequency of telomere fusions. In brief, ,80% confluent MEFs were incubated for 2 h with 0.2 mg ml 21 colcemid (Sigma). The cells were collected by trypsinization, resuspended in 0.075 M KCl at 37 uC for 30 min, and fixed overnight in methanol/acetic acid (3:1) at 4 uC. The cells were dropped onto glass slides and the slides were dried overnight. The next day, the slides were rehydrated with PBS for 15 min then fixed with 4% formaldehyde for 2 min at room temperature. Slides were digested with 1 mg ml 21 pepsin, pH 2.2, at 37 uC for 10 min, washed three times with PBS and fixed again in 4% formaldehyde for 2 min at room temperature. After three PBS washes, the slides were incubated consecutively with 75%, 95% and 100% ethanol and allowed to air dry for 30 min before applying hybridization solutions (70% formamide, 1 mg ml 21 blocking reagent (Roche), 10 mM Tris-HCl, pH 7.2) containing TAMRA-OO-(TTAGGG) 3 PNA probes (Applied Biosystems). Slides were denatured by heating for 3 min at 80 uC and hybridized for 2 h at room temperature. The next day, the slides were washed twice for 15 min each in 70% formamide, 10 mM Tris-HCl, followed by three 5-min washes in 0.1 M Tris-HCl, pH 7.0, 0.15 M NaCl and 0.08% Tween-20. Chromosomal DNA was counterstained with DAPI during the second PBS wash. Slides were mounted in antifade reagent (ProLong Gold, Invitrogen) and images were captured with a Nikon Eclipse TI microscope (see http://delangelab.rockefeller.edu/protocols). CO-FISH. Cells were labelled with BrdU:BrdC (3:1, final concentration 10 mM) for 14-16 h. Two hours before collection by trypsinization, 0.2 mg ml 21 colcemid was added to the media. To fix the cells and drop metaphases on a glass slide, the same procedure that was applied for FISH was followed. Slides were treated with 0.5 mg ml 21 RNase A (in PBS, DNase-free) for 10 min at 37 uC, incubated with 0.5 mg ml 21 Hoechst 33258 (Sigma) in 23SSC for 15 min at room temperature, and exposed to 365-nm ultraviolet light (Stratalinker 1800 UV irradiator) for 30 min. The slides were then digested twice with 800 U exonuclease III (Promega) at room temperature for 10 min each, washed with PBS and dehydrated through an ethanol series of 70%, 95% and 100%. After air-drying, slides were hybridized with Tamra-OO-(TTAGGG) 3 PNA probe in hybridization solution (70% formamide, 1 mg ml 21 blocking reagent (Roche) and 10 mM Tris-HCl, pH 7.2) for 2 h at room temperature. The slides were then washed for a few seconds with 70% formamide and 10 mM Tris-HCl, pH 7.2, and incubated with FITC-OO-(CCCTAA) 3 PNA probe in hybridization solution for 2 h. Slides were washed and mounted as described for FISH (see http://delangelab.rockefeller.edu/protocols). Western blot analysis. Cells were collected by trypsinization, lysed in 23 Laemmli buffer (100 mM Tris-HCl, pH 6.8, 200 mM dithiothreitol, 3% SDS, 20% glycerol and 0.05% bromophenol blue) at 1 3 10 4 cells per microlitre. The lysate was denatured for 10 min at 95 uC, and sheared by forcing it through a 28-gauge insulin needle ten times. Lysate from 1 3 10 5 cells was loaded on an SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked in 5% milk in TBS with 0.1% Tween-20 and incubated with primary antibody in TBS, 5% milk and 0.1% Tween-20 for 2 h at room temperature. The following primary antibodies were used: Polh (ab80906, Abcam); TRF1 (1449, rabbit polyclonal); RAP1 (1252, rabbit polyclonal); phospho-CHK2 (Thr68) (rabbit polyclonal, Cell Signaling); CHK2 (rabbit polyclonal, Cell Signaling); phospho-CHK1 (Ser 345) (mouse monoclonal, Cell Signaling); CHK1 (mouse monoclonal, Santa Cruz); LIG3 (mouse monoclonal, Santa Cruz); Myc (9E10; Calbiochem); and c-tubulin (clone GTU-88, Sigma); PARP1 (polyclonal, Cell signaling). (See http://delangelab.rockefeller.edu/protocols.) Chromosomal aberrancies. Cells were collected and dropped on microscope slides as described for the FISH protocol. After the slides had dried overnight, they were rehydrated in PBS, stained with 0.25 mg ml 21 DAPI, dehydrated in a 70%, 95% and 100% ethanol series, mounted and imaged using Nikon Eclipse TI microscope. Aberrancies were scored as a percentage of chromatid breaks, chromosome breaks, and chromosome radial structures compared to total number of chromosomes. Chromosomal translocation assay. Induced pluripotent stem cells were derived from primary Polq 1/1 and Polq 2/2 MEFs according to standard Yamanaka protocol 33 . To perform the translocation assay, Polq 1/1 and Polq 2/2 induced pluripotent stem cells were transfected with 2 mg of Cas9-gRNA(Rosa26;H3f3b) plasmid per million cell. We constructed Cas9-gRNA(Rosa26;H3f3b) by introducing two guide RNAs
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(59-GTTGGCTCGCCGGATACGGG-39 for H3f3b; 59-ACTCCAGTCTTTCTA GAAGA-39 for Rosa26) into pX330 (Addgene, 42230). After transfection, 1 3 10 4 cells were seeded per well in a 96-well plate, and lysed 3 days later in 40 ml lysis buffer (10 mM Tris, pH 8.0, 0.45% Nonidet P-40 and 0.45% Tween 20) . The lysate was incubated with 200 mg ml 21 proteinase K for 2 h at 55 uC. Translocation detection was performed according to previously established protocol 9 , using nested PCR. The primers used for the first PCR reaction were Tr6-11-Fwd: 59-GCGGG AGAAATGGATATGAA-39 and Tr6-11-Rev: 59-TTGACGCCTTCCTTCTTCT G-39 for der (6) , and Tr11-6-Fwd: 59-AACCTTTGAAAAAGCCCACA-39 and Tr11-6-Rev: 59-GCACGTTTCCGACTTGAGTT-39, for der (11) . For the second round of PCR amplification we used the primers Tr6-11NFwd: 59-GGCGGAT CACAAGCAATAAT-39 and Tr6-11NRev: 59-CTGCCATTCCAGAGATTGGT-39, and Tr11-6NFwd: 59-AGCCACAGTGCTCACATCAC-39 and Tr11-6NRev: 59TCCCAAAGTCGCTCTGAGTT-39. The number of PCR-positive wells was used to calculate the translocation frequency as previously described 9 . Amplified products from positive wells were sequenced to verify translocations and determine the junction sequences. Surveyor assay. Forty-eight hours after transfection, genomic DNA was extracted with GE Healthcare Illustra Genomic Prep Mini Spin Kit (28-9042-76) . The genomic region encompassing the guide RNA target sites was amplified using Q5 HighFidelity DNA polymerase (New England BioLabs) with the primers Rosa26-Fwd: 59-TAAAACTCGGGTGAGCATGT-39 and Rosa26-Rev: 59-GGAGTTCTCTGC TGCCTCCTG-39, and H3f3b-Fwd: 59-GCGGCGGCTTGATTGCTCCAG-39 and H3f3b-Rev: 59-AGCAACTTGTCACTCCTGAGCCAC-39. PCR fragments were gel purified and the surveyor assay was performed using a detection kit (Transgenomic), according to manufacturer's instructions. Agarose gels (2%) were used to visualize the bands after surveyor digestion. Colony formation assay. After lentiviral transduction with shCtrl or (sequences listed below), cells were selected with puromycin (BJ: 0.5 mg ml
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; MCF7 and HCC1937: 1 mg ml
; MEFs: 2 mg ml
) for 72 h and plated in 6-cm dishes (1,000 and 10,000 cells per plate). After 10-14 days, colonies were fixed with 3% paraformaldehyde (5 min), rinsed with PBS, and stained with crystal violet (Sigma-Aldrich). CRISPR targeting to mutate Polq gene in mouse embryonic stem cells. To generate cells carrying a catalytic dead Polh, two mutations at residues Asp2494Gly and Glu2495Ser (ref. 34) were introduced in the endogenous Polq locus in mouse embryonic stem cells using CRISPR/Cas9 gene targeting. Two guides RNAs were co-transfected with a Cas9-nickase (pX335-U6-Chimeric_BB-CBh-hSpCas9n(D10A)), and a donor cassette that introduces a SacII restriction site while replacing the two amino acid residues. Clonal cells lines were derived and genotyped to determine successful targeting. Two independent clonally derived lines were used for the analysis of translocation. Cre-ER T2 cells. e, Quantitative analyses of colony formation in BJ-hTERT, MCF7 and HCC1937 cells after LIG3 inhibition. The number of colonies in control-shRNA-treated cells was set to 100%. The knockdown efficiency for Lig3 was ,85%. Bars represent mean of two independent experiments 6 s.e.m. f. Quantitative analyses of colony formation in Polq CD and Polq 1/1 embryonic stem cells after BRCA1 inhibition. The number of colonies in controlshRNA-treated cells was set to 100%. The knockdown efficiency for BRCA1 was .80%. Bars represent mean of two independent experiments 6 s.e.m. *P 5 0.05; two-tailed Student's t-test.
